UV Germi Valuation
| ALUVI Stock | EUR 3.45 0.42 13.86% |
At this time, the company appears to be undervalued. UV Germi SA owns a latest Real Value of €3.9 per share. The recent price of the company is €3.45. Our model measures the value of UV Germi SA from analyzing the company fundamentals such as Profit Margin of (0.07) %, return on equity of -0.0619, and Current Valuation of 7.06 M as well as examining its technical indicators and probability of bankruptcy.
Undervalued
Today
Please note that UV Germi's price fluctuation is relatively risky at this time. Calculation of the real value of UV Germi SA is based on 3 months time horizon. Increasing UV Germi's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
UV Germi's intrinsic value may or may not be the same as its current market price of 3.45, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 3.45 | Real 3.9 | Hype 3.45 | Naive 3.47 |
The intrinsic value of UV Germi's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence UV Germi's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of UV Germi SA helps investors to forecast how ALUVI stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of UV Germi more accurately as focusing exclusively on UV Germi's fundamentals will not take into account other important factors: UV Germi Total Value Analysis
UV Germi SA is presently projected to have takeover price of 7.06 M with market capitalization of 12.02 M, debt of 323.46 K, and cash on hands of 4.37 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the UV Germi fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
7.06 M | 12.02 M | 323.46 K | 4.37 M |
UV Germi Investor Information
About 47.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 1.13. Some equities with similar Price to Book (P/B) outperform the market in the long run. UV Germi SA recorded a loss per share of 0.2. The entity had not issued any dividends in recent years. UV Germi SA is not in a good financial situation at the moment. It has a very high risk of going through financial straits in August.UV Germi Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. UV Germi has an asset utilization ratio of 81.24 percent. This connotes that the Company is making €0.81 for each dollar of assets. An increasing asset utilization means that UV Germi SA is more efficient with each dollar of assets it utilizes for everyday operations.UV Germi Ownership Allocation
The market capitalization of UV Germi SA is €12.02 Million. UV Germi SA shows serious amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Note, that even with negative profits, if the true value of the company is larger than the current market value, you may still be able to generate positive returns on investment in this company.UV Germi Profitability Analysis
The company reported the revenue of 6.32 M. Net Loss for the year was (869.52 K) with profit before overhead, payroll, taxes, and interest of 2.66 M.About UV Germi Valuation
The stock valuation mechanism determines UV Germi's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of UV Germi SA based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of UV Germi. We calculate exposure to UV Germi's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of UV Germi's related companies.UV GERMI, Socit anonyme develops and manufactures UV sterilizers for water treatment applications. The company offers its products for applications in the areas of drinking water, waste water, water in public swimming pools, rain water, air, and surfaces, as well as industrial water in food processing, pharmaceutical, and cosmetic industries. UV GERMI operates under Pollution Treatment Controls classification in France and is traded on Paris Stock Exchange. It employs 30 people.
8 Steps to conduct UV Germi's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates UV Germi's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct UV Germi's valuation analysis, follow these 8 steps:- Gather financial information: Obtain UV Germi's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine UV Germi's revenue streams: Identify UV Germi's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research UV Germi's industry and market trends, including the size of the market, growth rate, and competition.
- Establish UV Germi's growth potential: Evaluate UV Germi's management, business model, and growth potential.
- Determine UV Germi's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate UV Germi's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Additional Tools for ALUVI Stock Analysis
When running UV Germi's price analysis, check to measure UV Germi's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy UV Germi is operating at the current time. Most of UV Germi's value examination focuses on studying past and present price action to predict the probability of UV Germi's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move UV Germi's price. Additionally, you may evaluate how the addition of UV Germi to your portfolios can decrease your overall portfolio volatility.